id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-P-0749-0001,FDA,FDA-2026-P-0749,Citizen Petition from Apotex Inc.,Other,Citizen Petition,2026-01-26,2026,1,2026-01-26,2026-07-23,2026-05-08 20:03:22,,1,0,09000064b9182c73
FDA-2026-D-1255-0002,FDA,FDA-2026-D-1255,Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry,Other,Guidance,2026-04-15,2026,4,2026-04-15,2026-07-15,2026-05-15 09:00:20,,1,0,09000064b9282a2a
FDA-2025-D-6130-0002,FDA,FDA-2025-D-6130,Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry,Other,Guidance,2026-04-20,2026,4,2026-04-20,2026-06-23,2026-04-28 09:00:28,,1,0,09000064b92940ac
FDA-2025-D-7121-0002,FDA,FDA-2025-D-7121,"Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators; Draft Guidance for Industry and Food and Drug
Administration Staff",Other,Guidance,2026-04-20,2026,4,2026-04-20,2026-06-23,2026-05-06 09:00:15,,1,0,09000064b928d63f
FDA-2021-D-0613-0003,FDA,FDA-2021-D-0613,Stability Testing for Medicated Premixes (Revision 1); VICH GL8(R); Guidance for Industry; Draft Guidance; #91,Other,Guidance,2026-04-16,2026,4,2026-04-16,2026-06-16,2026-04-16 20:09:33,,1,0,09000064b9287b2e
FDA-2025-D-2837-0002,FDA,FDA-2025-D-2837,Questions and Answers About Requirements for Additional Traceability Records for Certain Foods: Guidance for Industry - Draft Guidance,Other,Guidance,2026-02-20,2026,2,2026-02-20,2026-05-22,2026-02-20 20:47:16,,1,0,09000064b91c9d9a
FDA-2026-N-1304-0001,FDA,FDA-2026-N-1304,Agenda for the U.S. Food and Drug Administration (FDA) Virtual Public Meeting Food Allergen Thresholds and Their Potential Applications 2-18-2026,Other,Agenda,2026-02-18,2026,2,2026-02-18,2026-05-20,2026-05-17 09:00:21,,1,0,09000064b91b5eeb
FDA-2025-D-6131-0002,FDA,FDA-2025-D-6131,General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance,Other,Guidance,2026-03-19,2026,3,2026-03-19,2026-05-19,2026-05-16 09:00:11,,1,0,09000064b9223609